Olympiad Research’s Stride LRN Stock Holding History

Olympiad Research’s Portfolio LRN Stock Details LRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,278	Closed	-$228K	–	325
2022 Q1	$228K	Buy	+6,278	New	+$208K	0.07%	245

Other funds holding LRN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Olympiad Research's LRN Position: Q2 2022 in Review

Olympiad Research sold out of Stride (LRN) in Q2 2022, closing a stake of 6,278 shares — an estimated $228K sold.

Olympiad Research first reported a position in LRN in Q1 2022 and held it in 1 quarter. The position peaked at $228K in Q1 2022. 219 funds tracked by Wall St. Rank hold LRN as of Q2 2022.

Olympiad Research reported no remaining Stride position as of Q2 2022 after selling out during the quarter.
Olympiad Research sold 6,278 Stride shares in Q2 2022, an estimated $228K.
Olympiad Research first reported a position in Stride in Q1 2022 and held it in 1 quarter.
Olympiad Research's Stride position peaked at $228K in Q1 2022.
219 funds tracked by Wall St. Rank held Stride as of Q2 2022.

Based on Olympiad Research's 13F filing for Q2 2022, filed 8 Aug 2022.